Ngā hua rapu - Sandip Pravin Patel

Whakamahine hua
  1. 1
    Next generation predictive biomarkers for immune checkpoint inhibition

    Next generation predictive biomarkers for immune checkpoint inhibition mā Yulian Khagi, Razelle Kurzrock, Sandip Pravin Patel

    I whakaputaina 2016
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    CEA/CD3-bispecific T cell-engaging (BiTE) antibody-mediated T lymphocyte cytotoxicity maximized by inhibition of both PD1 and PD-L1

    CEA/CD3-bispecific T cell-engaging (BiTE) antibody-mediated T lymphocyte cytotoxicity maximized by inhibition of both PD1 and PD-L1 mā Takuya Osada, Sandip Pravin Patel, Scott A. Hammond, Koya Osada, Michael A. Morse, H. Kim Lyerly

    I whakaputaina 2015
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Immune-Related Pneumonitis After Chemoradiotherapy and Subsequent Immune Checkpoint Blockade in Unresectable Stage III Non–Small-Cell Lung Cancer

    Immune-Related Pneumonitis After Chemoradiotherapy and Subsequent Immune Checkpoint Blockade in Unresectable Stage III Non–Small-Cell Lung Cancer mā Jarushka Naidoo, Mizuki Nishino, Sandip Pravin Patel, Bairavi Shankar, Natasha Rekhtman, Peter B. Illei, P. Camus

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Exceptional Response to Nivolumab and Stereotactic Body Radiation Therapy (SBRT) in Neuroendocrine Cervical Carcinoma with High Tumor Mutational Burden: Management Considerations from the Center For Personalized Cancer Therapy at UC San Diego Moores Cancer Center

    Exceptional Response to Nivolumab and Stereotactic Body Radiation Therapy (SBRT) in Neuroendocrine Cervical Carcinoma with High Tumor Mutational Burden: Management Considerations f... mā Andrew B. Sharabi, Sangwoo Shawn Kim, Shumei Kato, P. Dominick Sanders, Sandip Pravin Patel, Parag Sanghvi, Elizabeth Weihe, Razelle Kurzrock

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Hypermutated Circulating Tumor DNA: Correlation with Response to Checkpoint Inhibitor–Based Immunotherapy

    Hypermutated Circulating Tumor DNA: Correlation with Response to Checkpoint Inhibitor–Based Immunotherapy mā Yulian Khagi, Aaron M. Goodman, Gregory A. Daniels, Sandip Pravin Patel, Assuntina G. Sacco, James M. Randall, Lyudmila Bazhenova, Razelle Kurzrock

    I whakaputaina 2017
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Association of Patient Sex With Efficacy of Immune Checkpoint Inhibitors and Overall Survival in Advanced Cancers

    Association of Patient Sex With Efficacy of Immune Checkpoint Inhibitors and Overall Survival in Advanced Cancers mā Christopher J.D. Wallis, Mohit Butaney, Raj Satkunasivam, Stephen J. Freedland, Sandip Pravin Patel, Omid Hamid, Sumanta K. Pal, Zachary Klaassen

    I whakaputaina 2019
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Utility of Genomic Assessment of Blood-Derived Circulating Tumor DNA (ctDNA) in Patients with Advanced Lung Adenocarcinoma

    Utility of Genomic Assessment of Blood-Derived Circulating Tumor DNA (ctDNA) in Patients with Advanced Lung Adenocarcinoma mā Maria Schwaederlé, Sandip Pravin Patel, Hatim Husain, Megumi Ikeda, Richard B. Lanman, Kimberly C. Banks, AmirAli Talasaz, Lyudmila Bazhenova, Razelle Kurzrock

    I whakaputaina 2017
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Neutrophil to lymphocyte ratio and breast cancer risk: analysis by subtype and potential interactions

    Neutrophil to lymphocyte ratio and breast cancer risk: analysis by subtype and potential interactions mā Manuela Gago‐Dominguez, Marcos Matabuena, Carmen M. Redondo, Sandip Pravin Patel, Ángel Carracedo, Sara Miranda Ponte, Marı́a Elena Martı́nez, Jose E. Castelao

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Myocarditis occurrence with cancer immunotherapy across indications in clinical trial and post-marketing data

    Myocarditis occurrence with cancer immunotherapy across indications in clinical trial and post-marketing data mā Tigran Makunts, Ila M. Saunders, Isaac Cohen, Mengxing Li, Talar Moumedjian, M Issa, Keith Burkhart, Peter P. Lee, Sandip Pravin Patel, Ruben Abagyan

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers

    Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers mā Aaron M. Goodman, Shumei Kato, Lyudmila Bazhenova, Sandip Pravin Patel, Garrett M. Frampton, Vincent A. Miller, Philip J. Stephens, Gregory A. Daniels, Razelle Kurzrock

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    ALKBH5 regulates anti–PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment

    ALKBH5 regulates anti–PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment mā Na Li, Yuqi Kang, Lingling Wang, Sarah Huff, R. Tang, Hui Hui, Kriti Agrawal, Gwendolyn González, Yinsheng Wang, Sandip Pravin Patel, Tariq M. Rana

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    Use of Liquid Biopsies in Clinical Oncology: Pilot Experience in 168 Patients

    Use of Liquid Biopsies in Clinical Oncology: Pilot Experience in 168 Patients mā Maria Schwaederlé, Hatim Husain, Paul T. Fanta, David Piccioni, Santosh Kesari, Richard B. Schwab, Sandip Pravin Patel, Olivier Harismendy, Megumi Ikeda, Barbara A. Parker, Razelle Kurzrock

    I whakaputaina 2016
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Metastatic basal cell carcinoma with amplification of PD-L1: exceptional response to anti-PD1 therapy

    Metastatic basal cell carcinoma with amplification of PD-L1: exceptional response to anti-PD1 therapy mā Sadakatsu Ikeda, Aaron M. Goodman, Philip R. Cohen, Taylor J. Jensen, Christopher K. Ellison, Garrett M. Frampton, Vincent A. Miller, Sandip Pravin Patel, Razelle Kurzrock

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Dose escalation results from a first-in-human, phase 1 study of glucocorticoid-induced TNF receptor–related protein agonist AMG 228 in patients with advanced solid tumors

    Dose escalation results from a first-in-human, phase 1 study of glucocorticoid-induced TNF receptor–related protein agonist AMG 228 in patients with advanced solid tumors mā Ben Tran, Richard D. Carvajal, Aurélien Marabelle, Sandip Pravin Patel, Patricia LoRusso, Erik Rasmussen, Gloria Juan, Vijay Upreti, Courtney Beers, Gataree Ngarmchamnanrith, Patrick Schöffski

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Clinical implications of plasma circulating tumor DNA in gynecologic cancer patients

    Clinical implications of plasma circulating tumor DNA in gynecologic cancer patients mā Lindsey M. Charo, Ramez N. Eskander, Ryosuke Okamura, Sandip Pravin Patel, Mina Nikanjam, Richard B. Lanman, David Piccioni, Shumei Kato, Michael McHale, Razelle Kurzrock

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Disparities in telemedicine during COVID‐19

    Disparities in telemedicine during COVID‐19 mā Alexander S. Qian, Melody K. Schiaffino, Vinit Nalawade, L. Aziz, Fernanda Ventorim Pacheco, Bao Sean Nguyen, Peter Vu, Sandip Pravin Patel, Marı́a Elena Martı́nez, James D. Murphy

    I whakaputaina 2022
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    A Complete Response to Combined Immunotherapy in a Patient with an ATM plus SF3B1 Mutation and a Moderate Tumor Mutational Burden with a High-Grade Treatment-Emergent Neuroendocrine Prostate Cancer: Case Report and Review of the Literature

    A Complete Response to Combined Immunotherapy in a Patient with an ATM plus SF3B1 Mutation and a Moderate Tumor Mutational Burden with a High-Grade Treatment-Emergent Neuroendocrin... mā Helena Ferreira Bruzzi Porto, Gabriela Carreiro Kubitschek Lopes, Hannah Barboza Vianna Bekierman, Sérgio Altino de Almeida, Felipe Andreiuolo, Evandro Lucena, Sandip Pravin Patel, Vinicius Freire, Daniel Herchenhorn

    I whakaputaina 2024
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Revisiting Epidermal Growth Factor Receptor (<i>EGFR</i>) Amplification as a Target for Anti-EGFR Therapy: Analysis of Cell-Free Circulating Tumor DNA in Patients With Advanced Malignancies

    Revisiting Epidermal Growth Factor Receptor (<i>EGFR</i>) Amplification as a Target for Anti-EGFR Therapy: Analysis of Cell-Free Circulating Tumor DNA in Patients With Advanced Mal... mā Shumei Kato, Ryosuke Okamura, Manvita Mareboina, Suzanna Lee, Aaron M. Goodman, Sandip Pravin Patel, Paul T. Fanta, Richard B. Schwab, Peter Vu, Victoria M. Raymond, Richard B. Lanman, Jason K. Sicklick, Scott M. Lippman, Razelle Kurzrock

    I whakaputaina 2019
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Phase 1/2 study of monalizumab plus durvalumab in patients with advanced solid tumors

    Phase 1/2 study of monalizumab plus durvalumab in patients with advanced solid tumors mā Sandip Pravin Patel, Teresa Alonso‐Gordoa, Susana Banerjee, Ding Wang, Jarushka Naidoo, Nathan Standifer, Doug Palmer, Lin‐Yang Cheng, Panagiotis Kourtesis, Maria Libera Ascierto, Mayukh Das, Jennifer R. Diamond, Matthew D. Hellmann, Benedito A. Carneiro

    I whakaputaina 2024
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Change in neutrophil to lymphocyte ratio during immunotherapy treatment is a non-linear predictor of patient outcomes in advanced cancers

    Change in neutrophil to lymphocyte ratio during immunotherapy treatment is a non-linear predictor of patient outcomes in advanced cancers mā Mingjia Li, Daniel Spakowicz, Jarred Burkart, Sandip Pravin Patel, Marium Husain, Kai He, Erin M. Bertino, Peter G. Shields, David P. Carbone, Claire F. Verschraegen, Carolyn J. Presley, Gregory A. Otterson, Kari Kendra, Dwight H. Owen

    I whakaputaina 2019
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: